Ariad Pharmaceuticals, Inc. (ARIA)
$2.24
-0.05 (-2.18%)
| CAPS Rating |
|
|---|---|
| Open | $2.20 |
| Previous Close | $2.29 |
| Daily Range | $2.20 - $2.31 |
| 52-Week Range | $0.72 - $3.48 |
| Market Cap | $244.06M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 257,709 |
| Average Daily Volume | 2,035,000 |
ARIA
VS S&P 500 (SPY)
How do you think ARIA will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ARIA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ARIA News and Commentary
- 3 Stocks Ready to Roar – The Motley Fool
- UPDATE 1-Ariad says independent experts positive on cancer drug – Reuters
- Tomorrow's Monster Stock? – The Motley Fool
- 6 Stocks Attracting Top Investors – The Motley Fool
- Why Is everybody trashing Ariad Pharmaceuticals – Blog at The Motley Fool
- 2-Star Stocks Poised to Plunge: Ariad? – The Motley Fool
- Ariad Pharmaceutical – Blog at The Motley Fool
- Ariad Pharmaceutical leading gainer on NASDAQ – Blog at The Motley Fool
- Top-Rated Stocks That Treat Shareholders Right – The Motley Fool
- 3 Stocks Ready to Roar – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- Do These Stocks Deserve Your Support? – The Motley Fool
- 10 Stocks to Shake the Market – The Motley Fool
- Tomorrow's Monster Stocks – The Motley Fool
- Bayer's Little Lost Drug Patent – The Motley Fool
- Time to buy. – Blog at The Motley Fool
- Ariad's Lawsuit Loss and Investors' Gamble – The Motley Fool
- Alexza Establishes a Cash Pipeline – The Motley Fool
- Unloved Stocks Ready to Shine – The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
RSS Headlines
Fool UK
